Quick Takeaways
- S.H.N. Financial Investments Ltd. filed SCHEDULE 13G/A for Plus Therapeutics, Inc. Common Stock, $0.001 par value (PSTV).
- Disclosed ownership: 1.5%.
- Date of event: 14 Aug 2025.
S.H.N. Financial Investments Ltd. - 14 Aug 2025 SCHEDULE 13G/A Report for Plus Therapeutics, Inc. Common Stock, $0.001 par value (PSTV)
- Filing Manager
- S.H.N. Financial Investments Ltd.
- Reporting Manager
- S.H.N. Financial Investments Ltd.
- Symbol
- PSTV
- Shares outstanding
- 99,337,748 shares
- Disclosed Ownership
- 1,500,000 shares
- Ownership
- 1.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 18:52:56 UTC
- Date of event
- 14 Aug 2025
- Previous filing
- 18 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"S.H.N. Financial Investments Ltd. disclosed 1.5% ownership in Plus Therapeutics, Inc. Common Stock, $0.001 par value (PSTV) on 14 Aug 2025."
What Changed
- Previous schedule filing date: 18 Mar 2025.
- Current filing was accepted on 14 Aug 2025, 18:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| S.H.N. Financial Investments Ltd. | 1.5% | 1,500,000 | 1,500,000 | 0 | /s/ Nir Shamir | Nir Shamir, Chief Executive Officer |